The Patents, IP and licensing for IPF, ITV, and mAbs are part of Virogentics and Biogenysis, which are to become SAGA's wholly owned subsidiaries if the proposed transaction is completed. Under SAGA, Gaurav Chandra, Charles Cotropia, Joseph Cotropia, Suraj Saggar, and Kirsten Bischof would all have new roles in the subsidiaries, and Harry would assumedly continue his role as CSO of Virogentics. ENZC's latest disclosure says that there will eventually be a dividend to ENZC shareholders, then "there would be no assets or operations in Company E".
Below is the DD, straight from the source, if you would like it.
“Holy shit the number of people on this board totally misunderstanding this deal is alarming.”
Holy shit, how ironic. Bc literally every mab in the pipeline and every other asset is going to saga. 100%. What don’t people understand about 100%?!
Their own words yesterday. Post dividend payout ENZC will have “no assets” and “no operations”. It’s unreal that people cannot understand what that means.